Fort Washington Investment Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

Fort Washington Investment Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$388K	Hold	11,466	–	–	﹤0.01%	362
2026 Q1	$345K	Hold	11,466	–	–	﹤0.01%	368
2025 Q4	$358K	Sell	11,466 -378	-3%	-$9.31K	﹤0.01%	358
2025 Q3	$239K	Buy	+11,844	New	+$208K	﹤0.01%	395
2015 Q3	–	Sell	-44,228	Closed	-$2.61M	–	473
2015 Q2	$2.61M	Sell	44,228 -5,887	-12%	-$363K	0.05%	181
2015 Q1	$3.12M	Sell	50,115 -1,000	-2%	-$58.1K	0.06%	166
2014 Q4	$2.94M	Sell	51,115 -875	-2%	-$48.7K	0.06%	171
2014 Q3	$2.79M	Hold	51,990	–	–	0.06%	182
2014 Q2	$2.73M	Sell	51,990 -275	-0.5%	-$14.1K	0.05%	205
2014 Q1	$2.76M	Sell	52,265 -34,500	-40%	-$1.59M	0.06%	177
2013 Q4	$3.48M	Sell	86,765 -1,609	-2%	-$63.4K	0.08%	174
2013 Q3	$3.34M	Buy	88,374 +4,013	+5%	+$157K	0.08%	184
2013 Q2	$3.31M	Buy	+84,361	New	+$3.29M	0.08%	223

Other funds holding TEVA

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

AIIMS

Analyst IMS Investment Management Services Tel-Aviv, Israel $4.3B AUM 37.33% 1-Year Est. Return

UBP

Union Bancaire Privee Geneva 1, Switzerland $9.16B AUM 31.4% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

FAF

Fjarde Ap-fonden Stockholm, Sweden $20.9B AUM 36.93% 1-Year Est. Return

AAP

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return

Fort Washington Investment Advisors's TEVA Position: Q2 2026 in Review

Fort Washington Investment Advisors held its Teva Pharmaceuticals (TEVA) position steady in Q2 2026 at 11,466 shares worth $388K. The position accounts for ﹤0.01% of the portfolio, ranked #362.

Fort Washington Investment Advisors first reported a position in TEVA in Q2 2013 and has held it in 13 quarters since. The position peaked at $3.48M in Q4 2013. 218 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Fort Washington Investment Advisors held 11,466 shares of Teva Pharmaceuticals worth $388K as of Q2 2026.
Fort Washington Investment Advisors left its Teva Pharmaceuticals share count unchanged in Q2 2026.
Teva Pharmaceuticals made up ﹤0.01% of Fort Washington Investment Advisors's portfolio in Q2 2026, its #362 holding.
Fort Washington Investment Advisors first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 13 quarters since.
Fort Washington Investment Advisors's Teva Pharmaceuticals position peaked at $3.48M in Q4 2013.
218 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Fort Washington Investment Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.